- Home
- OMDA vs ETON Comparison
OMDA vs ETON Comparison
Compare OMDA & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OMDA | ETON |
|---|---|---|
| Founded | 2011 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2025 | 2018 |
Fundamental Metrics
Financial Performance| Metric | OMDA | ETON |
|---|---|---|
| Price | $23.89 | $63.47 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 3 |
| Target Price | $21.73 | ★ $39.33 |
| AVG Volume (30 Days) | ★ 1.6M | 624.0K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.27 | N/A |
| EPS | 0.04 | ★ 0.41 |
| Revenue | ★ $260,210,000.00 | $79,950,000.00 |
| Revenue This Year | $24.96 | $40.90 |
| Revenue Next Year | $20.08 | $47.23 |
| P/E Ratio | $592.75 | ★ $146.12 |
| Revenue Growth | 53.24 | ★ 104.94 |
| 52 Week Low | $10.28 | $14.27 |
| 52 Week High | $26.92 | $63.83 |
Technical Indicators
Market Signals| Indicator | OMDA | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 58.92 | 73.46 |
| Support Level | $14.39 | $15.66 |
| Resistance Level | $24.80 | N/A |
| Average True Range (ATR) | 1.17 | 3.26 |
| MACD | 0.12 | 1.56 |
| Stochastic Oscillator | 81.55 | 97.50 |
Price Performance
Historical ComparisonAbout OMDA Omada Health Inc.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.